Helsinki University Central Hospital

Helsinki University Central Hospital logo
🇫🇮Finland
Ownership
Private
Established
1958-03-01
Employees
10K
Market Cap
-
Website
http://www.hus.fi
nature.com
·

Automated and closed clinical-grade manufacturing protocol produces potent NK cells

The study involved ethical approval, leukapheresis for NK cell production, and adherence to GMP regulations. NK cells were manufactured using CliniMACS Prodigy, with quality control including sterility testing, cell count, and viability analysis. Cell lines and primary NK cells were isolated and cultured for cytotoxicity and degranulation assays.
© Copyright 2024. All Rights Reserved by MedPath